Browsing Tag
Melbourne
52 posts
Algorae Pharmaceuticals (ASX: 1AI) raises A$4m to fund dual commercial and AI drug discovery growth strategy
Algorae Pharmaceuticals (ASX: 1AI) raises A$3.99m to scale AlgoraeRx commercial portfolio and advance AlgoraeOS AI drug pipeline. Read the full strategic analysis.
April 5, 2026
Catapult Sports (ASX: CAT) posts record 27-28% ACV growth in FY26 trading update as dual acquisitions reshape the sports analytics platform
Catapult Sports (ASX: CAT) records 27-28% ACV growth and 50% EBITDA jump in FY26. Read what the dual acquisitions mean for the sports analytics race. Read more.
March 27, 2026
Careteq (ASX: CTQ) raises A$2.2m at steep discount to fund acquisitions and clear debt as stock trades near 52-week low
Careteq (ASX: CTQ) raises A$2.2M via a two-tranche placement at A$0.005 per share to fund acquisitions, repay debt, and support working capital. Read the full analysis.
March 11, 2026
Polynovo stock falls as diabetes wound trial results spotlight NovoSorb promise
Polynovo (ASX: PNV) shares slipped 1.37% as NovoSorb diabetes wound trial results showed faster healing in large wounds. Can reimbursement shifts revive growth?
September 13, 2025
Metal Logic bets on modular smelting in Pilbara to reshape steel costs and sustainability
Metal Logic secures a Pilbara site to launch its modular low-emission smelting platform, aiming to cut steel costs, extend mine life, and boost green jobs.
September 11, 2025
Accenture expands Asia Pacific cybersecurity dominance with CyberCX acquisition
Accenture acquires CyberCX, its largest Asia Pacific cybersecurity deal, adding 1,400 experts and AI-driven security platforms to boost resilience.
August 15, 2025
Australian man shot dead in Bali villa: Arrest made as underworld links and second suspect emerge
One Australian killed, another wounded in a Bali villa shooting. Read how underworld ties and diplomatic complexities are shaping the high-stakes investigation.
June 16, 2025
Chimeric Therapeutics secures new funding boost as cancer cell therapy trials accelerate
Discover how Chimeric Therapeutics' A$1M entitlement offer will drive innovation across CAR-T and NK cell therapy programs. Read the full story here.
April 27, 2025
Textron Aviation expands aircraft service capabilities with new facility at Essendon Fields airport
Textron Aviation is expanding its presence in Australia with the construction of a new aircraft service facility at…
February 17, 2025
Adore Beauty partners with tutch to power endless aisle capabilities for retail expansion
Adore Beauty Group Ltd. (ASX: ABY), Australia’s premier online beauty retailer, has announced a strategic partnership with tutch,…
February 10, 2025